Et tilfælde af toksisk encefaloneuropati under behandling med nimorazol

Shanga Hassan Qadir*, Ruta Jakubauskaite, Emilie Lund Laursen

*Corresponding author af dette arbejde

Abstract

5-nitroimidazoles (5-NI) are pharmacologically diverse drugs used mainly for anaerobic and parasitic infections. Metronidazole is the most widely used 5-NI and has rare neurotoxic effects, including cerebellar and brainstem dysfunction, encephalopathy, and seizures. Other (5-NI) have been studied as hypoxic cell radiosensitizers but are limited by dose-dependent side effects. Nimorazole is in use in Denmark for head-and-neck cancer and is considered safe. No cases of nimorazole-induced neurotoxicity like Metronidazole encephalopathy have been published. In this case, we report a patient who developed toxic encephaloneuropathy during nimorazole radiosensitisation.

Bidragets oversatte titelA case of toxic encephaloneuropathy during treatment with nimorazole
OriginalsprogDansk
ArtikelnummerV12240878
TidsskriftUgeskrift for Laeger
Vol/bind187
Udgave nummer29
Sider (fra-til)1-3
Antal sider3
ISSN0041-5782
DOI
StatusUdgivet - 14 jul. 2025

Emneord

  • Humans
  • Metronidazole/adverse effects
  • Male
  • Neurotoxicity Syndromes/etiology
  • Radiation-Sensitizing Agents/adverse effects
  • Middle Aged

Fingeraftryk

Dyk ned i forskningsemnerne om 'Et tilfælde af toksisk encefaloneuropati under behandling med nimorazol'. Sammen danner de et unikt fingeraftryk.

Citationsformater